Skip to main content
TipRanks
Go Ultimate75% OFF

Greenwich LifeSciences (GLSI) Ratios

451 Followers

Greenwich LifeSciences Ratios

GLSI's free cash flow for Q2 2026 was $-1.94M. For the 2026 fiscal year, GLSI's free cash flow was increased by $0.00 and operating cash flow was $-1.94M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.062.6223.7451.2370.63
Quick Ratio1.062.6223.7451.2370.63
Cash Ratio1.062.6223.7451.2370.63
Solvency Ratio-3.32-11.16-30.19-29.75-11.86
Operating Cash Flow Ratio-1.70-4.66-22.01-23.58-11.14
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 353.22K$ 2.53M$ 6.70M$ 13.21M$ 26.82M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio17.491.621.041.021.01
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA0.320.240.751.685.92
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT99.54%98.74%95.33%97.33%99.40%
Return on Assets (ROA)-313.34%-425.38%-127.12%-58.06%-16.79%
Return on Equity (ROE)-5480.55%-687.21%-132.71%-59.22%-17.03%
Return on Capital Employed (ROCE)-5505.94%-696.01%-139.21%-60.85%-17.14%
Return on Invested Capital (ROIC)-5505.94%-696.01%-139.21%-60.85%-17.14%
Return on Tangible Assets-313.34%-425.57%-127.22%-58.10%-16.80%
Earnings Yield-6.81%-11.91%-6.58%-3.99%-1.45%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.000.100.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-1000105.95-118992.43-3584.520.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding1000105.95118992.433584.520.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.73-0.56-0.50-0.48-0.33
Free Cash Flow Per Share-0.73-0.56-0.50-0.48-0.33
Dividend Paid and CapEx Coverage Ratio-3304484.33-2422181.000.00-2066675.670.00
Capital Expenditure Coverage Ratio-3304484.33-2422181.000.00-2066675.670.00
Operating Cash Flow Coverage Ratio0.000.000.000.000.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-3.49%-4.97%-4.79%-3.16%-1.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-14.69-9.28-15.20-25.08-68.90
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio805.0957.6820.1714.8511.74
Price-to-Free Cash Flow (P/FCF) Ratio-28.69-20.11-20.86-31.66-73.38
Price-to-Operating Cash Flow Ratio-28.69-20.11-20.86-31.66-73.38
Price-to-Earnings Growth (PEG) Ratio-0.81-0.12-1.16-0.34-0.52
Enterprise Value Multiple-14.37-8.16-13.75-22.75-62.63
Enterprise Value278.19M142.06M128.17M182.82M287.73M
EV to EBITDA-14.37-8.16-13.75-22.75-62.63
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-28.06-19.55-19.78-29.49-67.04
EV to Operating Cash Flow-28.06-19.55-19.78-29.49-67.04
Tangible Book Value Per Share0.030.190.521.022.07
Shareholders’ Equity Per Share0.030.190.521.022.07
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.43-1.34-0.69-0.61-0.35
Tax Burden1.001.001.001.001.00
Interest Burden1.001.000.950.970.99
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.510.460.730.790.94

Currency in USD